MedTrace Logo

Screening For BCRL In Targeted Therapy For Breast Cancer

NCT05142800 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 166

Last updated 2025-05-22

No results posted yet for this study

Summary

This a prospective, longitudinal study designed to track edema and Breast Cancer Related Lymphedema (BCRL) onset in breast cancer patients taking targeted therapy treatments for early and metastatic breast cancer.

A Perometer and Sozo devise will be used to measure volume changes

Conditions

  • Lymphedema
  • Lymphedema Arm
  • Lymphedema of Upper Arm
  • Lymphedema of Upper Limb
  • Lymphedema of the Hands
  • Edema
  • Edema Arm
  • Breast Cancer Lymphedema
  • Breast Cancer Metastatic
  • Breast Cancer Stage
  • Breast Cancer

Interventions

DEVICE

Perometer

The perometer uses light sensors to calculate the length and volume of your arms

DEVICE

SOZO device

The machine measures the amount of fluid on the arm(s)

Sponsors & Collaborators

  • Heinz Family Foundation

    collaborator UNKNOWN

  • Massachusetts General Hospital

    lead OTHER

Principal Investigators

  • Alphonse G. Taghian, MD · Massachusetts General Hospital

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-13
Primary Completion
2026-09-30
Completion
2026-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05142800 on ClinicalTrials.gov